Skip to main content
SpringerLink
Log in

The Adrenal Incidentaloma: Disease of Modern Technology and Public Health Problem

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Turnock BJ. Public Health: What it is and How it Works. 2nd edn. Gaithersburg, MD: Aspen Publishers, Inc., 2001.

    Google Scholar 

  2. Griffing CT. AIDS: The new endocrine epidemic. J Clin Endocrinol Metab 1994;79:1530-1531.

    Google Scholar 

  3. Patz EF Jr, Goodman PC, Bepler G. Screeening for lung cancer. N Engl J Med 2000;343:1627-1633.

    Google Scholar 

  4. Aron DC (ed.). Endocrine incidentalomas. Endocrinol Metab Clin NA 2000;29:1-238.

  5. Young WE Jr. Adrenal incidentalomas: Management approaches to adrenal masses discovered incidentally on abdominal imaging. Endocrinol Metab Clin NA 2000;1:159-186.

    Google Scholar 

  6. Kievit J, Haak HR. Diagnosis and treatment of adrenal incidentaloma: A cost-effectiveness analysis. Endocrinol Metab Clin NA 2000;1:69-90.

    Google Scholar 

  7. Linos DA. Management approaches to adrenal incidentalomas (adrenalomas): A view from Athens, Greece. Endocrinol Metab Clin NA 2000;29:141-158.

    Google Scholar 

  8. Mantero F, Giorgic Arnaldi G. Management approaches to adrenal incidentalomas: A view from Ancona, Italy. Endocrinol Metab Clin NA 2000;1:107-126.

    Google Scholar 

  9. Schteingart DE. Management approaches to adrenal incidentalomas: A view from Ann Arbor, Michigan. Endocrinol Metab Clin NA 2000;29:127-140.

    Google Scholar 

  10. Cook DM, Loriaux DL. The incidental adrenal mass. Adv in Endocrinol Metabol 1994;5:137-170.

    Google Scholar 

  11. Kloos RT, Gross MD, Francis IR, Korobkin M, Shapiro B. Incidentally discovered adrenal masses. Endocrine Reviews 1995;16:460-484.

    Google Scholar 

  12. Lightner ES, Levine LS. The adrenal incidentaloma. A pediatric perspective. Am J Dis Children 1993;147:1274-1276.

    Google Scholar 

  13. Aron DC. Adrenal incidentalomas and glucocorticoid autonomy. Clin Endocrinol 1998;49:157-158.

    Google Scholar 

  14. Reincke M. Subclinical Cushing's Syndrome. Endocrinol Metab Clin NA 2000;1:43-56.

    Google Scholar 

  15. Rossi R, Tauchmanova L, Luciano A, Di Martino M, Battista C, Del Viscovo L, Nuzzo V, Lombardi G. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 2000;85:1440-1448.

    Google Scholar 

  16. Torlontano M, Chiodini I, Pileri M, Guglielmi G, Cammisa M, Modoni S, Carnevale V, Trischitta V, Scillitani A. Altered bone mass and turnover in female patients with adrenal incidentaloma: the effect of subclinical hypercortisolism. J Clin Endocrinol Metab 1999;84:2381-2385.

    Google Scholar 

  17. Tsaragakis S, Roboti C, Kokkoris P, Vasiliou V, Alevizaki C, Thalassinos. Elevated post-dexamethasone suppression cortisol concentrations correlate with hormonal alterations of the hypothalamo-pituitary adrenal axis in patienta with adrenal incidentalomas. Clin Endocrinol. 1998;49:165-171.

    Google Scholar 

  18. Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Ali A, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study group on adrenal tumors of the Italian society of endocrinology. J Clin Endocrinol Metab 2000;85:637-644.

    Google Scholar 

  19. Stratakis CA, Chrousos GP. Adrenal cancer. Endocrinol Metab Clin NA 2000;29:15-26.

    Google Scholar 

  20. Terzolo M, Ali A, Osella G, Mazza E. Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 1997;132:914-919.

    Google Scholar 

  21. Favia G, Lumachi F, Basso S, D'Amico DF. Management of incidentally discovered adrenal masses and risk of malignancy. Surgery 2000;128:918-924.

    Google Scholar 

  22. Luton JP, Martinez M, Coste J, Bertherat J. Outcome in patients with adrenal incidentaloma selected for surgery: An analysis of 88 cases investigated in a single clinical center. Eur J Endocrinol 2000;143:111-117.

    Google Scholar 

  23. Bernini GP, Miccoli P, Moretti A, Vivaldi MS, Iacconi P, Salvetti A. Sixty adrenal masses of large dimensions: Hormonal and morphologic evaluation. Urology 1998;51:920-925.

    Google Scholar 

  24. Udelsman R, Fishman EK. Radiology of the adrenal. Endocrinol Metab Clin NA 2000;29:27-42.

    Google Scholar 

  25. Aron DC. Diagnostic implications of adrenal physiology and clinical epidemiology for evaluation of glucocorticoid excess and deficiency. In: DeGroot LJ, Jameson JL, eds. Endocrinology, 4th edn. Philadelphia: W.B. Saunders, 2000;1655-1670.

    Google Scholar 

  26. Bailey RH, Aron DC. The diagnostic dilemma of incidentalomas: working through uncertainty. Endocrinol Metab Clin NA 2000;29:91-105.

    Google Scholar 

  27. Black WC, Welch HG. Advances in diagnostic imaging and overestimation of disease prevalence and the benefits of therapy. N Engl J Med 1993;328:1237-1243.

    Google Scholar 

  28. Marshall KG. Prevention. How much harm? How much benefit? 1. Influence of reporting methods on perception of benefits. Can Med Assoc J 1996;154:1493-1499.

    Google Scholar 

  29. Marshall KG. Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits. Can Med Assoc J 1996;154:1837-1843.

    Google Scholar 

  30. Marshall KG. Prevention. How much harm? How much benefit? 3. Physical, psychological and social harm. Can Med Assoc J 1996;155:169-175.

    Google Scholar 

  31. Seppel T, Schlaghecke R. Augmented 17 alpha-hydroxypro-gesterone response to ACTH stimulation as evidence of decreased 21-hydroxylase activity in patients with incidentally discovered adrenal tumours (“incidentalomas”). Clin Endocrinol 1994;41:445-451.

    Google Scholar 

  32. Terzolo M, Ali A, Osella G, Reimondo G, Pia A, Peretti P, Paccotti P, Angeli A. The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses. Eur J Endocrinol 2000;142:611-617.

    Google Scholar 

  33. Gicquel C, Bertherat J, Le Bouc Y, Bertagna X. Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms. Endocrinol Metab Clin NA 2000;29:1-14.

    Google Scholar 

  34. Mold JW, Stein HF. The cascade effect in the clinical care of patients. N Engl J Med 1986;314:512-514.

    Google Scholar 

  35. Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J, Migdalska B, Jeske W, Makowska A, Snochowska H. Incidentally discovered adrenal mass (incidentaloma): Investigation and management of 208 patients. Clin Endocrinol 1997;46:29-37.

    Google Scholar 

  36. Virkkala A, Valimaki M, Pelkonen R, Huikuri K, Kahri A, Kivisaari L, Korhonen T, Salmi J, Seppala P. Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. Acta Endocrinologica (Copenh) 1989;121:67-72.

    Google Scholar 

  37. Jockenhovel F, Kuck W, Hauffa B, Reinhardt W, Benker G, Lederbogen S, Olbricht Th., Reinwein D. Conservative and surgical management of incidentally discovered adrenal tumors (incidentalomas). J Endocrinol Invest 1992;15:331-337.

    Google Scholar 

  38. Barry MK, van Heerden JA, Farley DR, Grant CS, Thompson GB, Ilstrup DM. Can adrenal incidentalomas be safely observed? World J Surg 1998;22:599-604.

    Google Scholar 

  39. Barzon L, Scaroni C, Sonino N, Fallo F, Paoletta A, Boscaro M. Risk factors and long-term follow-up of adrenal incidentalomas. J Clin Endocrinol Metab 1999;84:520-526.

    Google Scholar 

  40. Bastounis EA, Karayiannakis AJ, Anapliotou ML, Nakopoulou L, Makri GG, Papalambros EL. Incidentalomas of the adrenal gland: diagnostic and therapeutic implications. Am Surg 1997;63:356-360.

    Google Scholar 

  41. Siren J, Tervahartiala P, Sivula A, Haapiainen R. Natural course of adrenal incidentalomas: Seven-year follow-up study. World J Surg 2000;24:579-582.

    Google Scholar 

  42. Jossart GH, Burpee SE, Gagner M. Surgery of the adrenal glands. Endocrinol Metab Clin NA 2000;29:57-68.

    Google Scholar 

  43. Slavin LP, Best MA, Aron DC. To Regionalize or not to regionalize: that is the question. Part I. Volume-outcome relationships--conceptual framework. The Endocrinologist 2000;10:205-210.

    Google Scholar 

  44. Best MA, Slavin LP, Aron DC. To Regionalize or not to regionalize: that is the question. Part II. Volume-outcome relationships--endocrine disorders and their treatment. The Endocrinologist 2000;10:265-269.

    Google Scholar 

  45. Fisher ES, Welch HG. Avoiding the unintended consequences of growth in medical care: how might more be worse? JAMA 1999;281:446-453.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical and Molecular Endocrinology, Department of Medicine, Case Western Reserve University School of Medicine, and Louis Stokes Department of Veterans Affairs Medical Center, Cleveland, Ohio

    David C. Aron

Authors
  1. David C. Aron
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aron, D.C. The Adrenal Incidentaloma: Disease of Modern Technology and Public Health Problem. Rev Endocr Metab Disord 2, 335–342 (2001). https://doi.org/10.1023/A:1011580819132

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1011580819132

Search

Navigation